Kezar Life Sciences, Inc. Common Stock (KZR) Stock Price

KZRStock

$0.00−88.09%52W

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta-1.20

KZR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)9.25%

Price vs S&P 500 (4W)-9.39%

VGM Score44.39

Book Value / Share (Quarterly)$9.56

P/TBV (Annual)0.25x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-7.06

Price vs S&P 500 (YTD)7.73%

Net Profit Margin (TTM)-1254.16%

EPS (TTM)$-7.66

10-Day Avg Trading Volume0.13M

EPS Excl Extra (TTM)$-7.66

EPS (Annual)$-7.66

ROI (Annual)-79.96%

Cash / Share (Quarterly)$9.80

ROA (Last FY)-73.11%

EBITD / Share (TTM)$-7.96

ROE (5Y Avg)-51.78%

Operating Margin (TTM)-1383.84%

Cash Flow / Share (Annual)$-7.06

P/B Ratio0.77x

P/B Ratio (Quarterly)0.66x

Net Income / Employee (Annual)$-6,225,900

ROA (TTM)-54.83%

EPS Incl Extra (Annual)$-7.66

Current Ratio (Annual)11.52x

Quick Ratio (Quarterly)11.34x

3-Month Avg Trading Volume0.07M

52-Week Price Return-88.09%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$2.97

P/S Ratio (Annual)7.69x

Asset Turnover (Annual)0.03x

52-Week High$7.55

EPS Excl Extra (Annual)$-7.66

CapEx CAGR (5Y)-46.93%

Tangible BV CAGR (5Y)38.88%

26-Week Price Return17.39%

Quick Ratio (Annual)11.34x

13-Week Price Return20.90%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)11.52x

Enterprise Value$-18.02M

Asset Turnover (TTM)0.03x

Book Value / Share Growth (5Y)25.77%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-1455.29%

Cash / Share (Annual)$9.80

3-Month Return Std Dev48.11%

Net Income / Employee (TTM)$-6,225,900

ROE (Last FY)-79.96%

EPS Basic Excl Extra (Annual)$-7.66

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-7.66

ROI (TTM)-60.32%

P/S Ratio (TTM)9.50x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$3.94

Price vs S&P 500 (52W)-89.48%

Year-to-Date Return15.90%

5-Day Price Return-1.35%

EPS Normalized (Annual)$-7.66

ROA (5Y Avg)-44.98%

Net Profit Margin (Annual)-1455.29%

Month-to-Date Return-0.27%

Cash Flow / Share (TTM)$-1.20

EBITD / Share (Annual)$-7.96

Operating Margin (Annual)-1591.77%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-49.63%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-7.66

P/TBV (Quarterly)0.31x

P/B Ratio (Annual)0.66x

Pretax Margin (TTM)-1254.16%

Book Value / Share (Annual)$9.56

Price vs S&P 500 (13W)12.04%

Beta-1.20x

Revenue / Share (TTM)$0.00

ROE (TTM)-64.42%

52-Week Low$3.53

mGradeC

vgmGradeC

KZR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.56

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
KZRKezar Life Sciences, Inc. Common Stock	—	—	C	$0.00
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Kezar Life Sciences, Inc. Common Stock

Kezar Life Sciences is a clinical-stage biotechnology company developing small molecule therapeutics for autoimmunity and cancer indications. The company's pipeline includes lead candidates Zetomipzomib (KZR-616) and KZR-261, designed to address significant unmet medical needs in these therapeutic areas.